Marshall Edwards, Inc. (MSHL) Cancer Drug Success Continues, IND Submitted to FDA for ME-344, Advances Made in ME-143 Trials
Today, Marshall Edwards, which is steadily breaking new ground in the field of cancer therapeutics via naturally occurring isoflavone compounds…